Inditrade Cap.

- Inditrade Capital is actively working with multiple PSU banks and institutions to access new borrowing, especially for microfinance growth, having just completed a three-year track record required by PSU banks. - The company recently secured a working capital loan from SIDBI at a favorable rate and is exploring loans from other organizations like NABARD. - They aim to shift the borrowing mix from 85% NBFC and 15% banks to about 50:50, which should reduce the cost of funds significantly. - No mention of immediate equity fundraising is made; focus is on debt and improving borrowing costs. - They plan to build a "war chest" by increasing borrowings while cash flows remain comfortable, preparing to lend aggressively once market conditions stabilize.

- No significant capital expenditure planned for insurance broking segment as of August 2020; branches and infrastructure are already in place. - Insurance broking business expansion focused on ramping up retail piece, leveraging existing branches without further capital outlay. - Insurance broking not capital-intensive; no new branch openings required, thus no further capital expenditure expected. - Acquisition of Sistema Business Scalerator team onboarded, but no company/assets/liabilities acquired; fits into an existing idle subsidiary. - Changing the name and business object of the subsidiary to reflect distribution of third-party products (including Inditrade’s) - likely minimal capex. - Overall, no major capital commitments; focus is on operational leverage and synergy realization rather than capital investment. - Working capital loans and funding are being managed through borrowings, with no mention of new strategic capital investments.

- Insurance broking segment: Expecting a significant pickup in the latter half of 2020 after COVID disruptions, with no further capital expenditure planned as branches are set up. Synergies with other segments via mandatory insurance for microfinance and MSME customers are strong. Hopeful to start earning significant revenue by year-end. - Microfinance: Targeting reduction in cost of funds by increasing borrowing from PSU banks, aiming to reduce interest cost from 14.88% to around 12% within a year and potentially further in two years, which would support growth. Disbursements to restart in stable regions like Karnataka, with cautious calibrated lending. - MSME and Agri segments: Interest rates and borrowing costs expected to decrease (Agri rates from 9.56% to approx. 8-8.5%, MSME below 10%), supporting better growth. Agri business disbursing loans continuously with good margins due to favorable commodity prices. - New team from Sistema acquisition to enhance distribution in South India, operating across 306 towns, expected to contribute to growth in distribution of financial products. - Overall growth is cautiously optimistic, dependent on economic recovery and easing of COVID-related disruptions.

- Inditrade Capital aims to ramp up its insurance broking business, expecting significant volume growth in the latter half of 2020 due to increased insurance demand post-COVID. - Cost of funds is expected to reduce, especially in microfinance, with a target to bring the borrowing cost down from 14.88% to around 12% within a year, and possibly lower in two years, improving margins. - Agri and MSME lending rates are also expected to decline, potentially leading to improved profitability in these segments. - The company has controlled expenses significantly despite COVID challenges and acquired a new distribution team (Sistema), which is expected to be cash breakeven by December, contributing positively going forward. - Management is cautiously optimistic to improve earnings and EPS with an expected uptick in disbursements and collections in H2 FY21. - No further capital expenditure planned, reducing financial strain on profitability. - Overall, Inditrade expects a gradual return to growth and better profitability supported by diversified segments and operational efficiencies.

The transcript of the Inditrade Capital Limited Q1 FY’21 earnings call dated August 7, 2020, does not specifically mention current or expected order book or pending orders. Key points related to business outlook include: - Focus remains on microfinance, MSME finance, micro-lending, and agri commodity finance. - AUM stands at INR 450 crores with a balance sheet size of INR 479 crores as of June 30, 2020. - Disbursements have been minimal due to COVID-19, except for some in agri and micro-loan segments. - Agri business disbursements are ongoing and expected to grow due to favorable market conditions. - Microfinance and MSME disbursements are subdued but expected to improve as collections normalize. - The company is building a war chest by borrowing now to be ready for lending when market conditions improve. No direct information on order book size or pending orders was disclosed.